Riskpilot← Back to searchSign inGet full accessRenF AB
ABActiveOrg 5568688773Gåsmossen 30Medical specialists activities · NACE 8622Est. 20110 employees
Revenue 2025
SEK 1,4M
+7% vs 2024
EBITDA margin
83.4%
+423% vs 2024
Equity ratio
54.6%
Financial strength
Net profit 2025
SEK 807K
+437% vs 2024
| Revenue | SEK 1,4M | +7% |
| EBITDA | SEK 1,2M | +423% |
| Net profit | SEK 807K | +437% |
| Total assets | SEK 1,6M | +137% |
| Equity | SEK 858K | +328% |
| Employees | 0 | — |
Legal name
RenF AB
Org number
5568688773
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
25 oktober 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva medicinska specialtjänster till sjukhus och mottagningar samt medicinska utbildningstjänster, bedriva verksamhets- och ledarskapsutvecklingstjänster till offentliga och privata organisationer och företag, bedriva handel med värdepapper, bedriva uthyrningsverksamhet av rum och fastigheter samt bedriva därmed förenlig verksamhet.
Address
Gåsmossen 30
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 441 | 1 404 | 1 242 | 1 316 | 1 413 |
| Staff expenses | — | −1 047 | −1 039 | −1 007 | −55 |
| EBITDA | 287 | 151 | 41 | 225 | 1 178 |
| Depreciation & amort. | −0 | — | — | −36 | −39 |
| EBIT | 287 | 151 | 41 | 189 | 1 138 |
| Net financials | −137 | 0 | 0 | 1 | 0 |
| Profit before tax | 328 | 152 | 41 | 190 | 1 019 |
| Tax | −49 | −31 | −9 | −40 | −212 |
| Net profit | 279 | 120 | 32 | 150 | 807 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 568 | 706 | 530 | 664 | 1 570 |
| Equity | 455 | 275 | 87 | 200 | 858 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 114 | 431 | 443 | 463 | 592 |
| Total debt | 114 | 431 | 443 | 463 | 592 |
EBITDA margin
83.4%
This company
15.8%
Market median
+428% vs market
20212025
Equity ratio
54.6%
This company
38.2%
Market median
+43% vs market
20212025
Return on equity
94.1%
This company
18.4%
Market median
+411% vs market
20212025
Net profit margin
57.1%
This company
8.1%
Market median
+605% vs market
20212025
Asset turnover
0.90×
This company
1.12×
Market median
+20% vs market
20212025
Debt / equity
0.83×
This company
0.62×
Market median
+34% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RenF AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emma Marie Bjuhr | Deputy Board Member | 0 companies |
| Bengt Örjan Bjuhr | Board of Directors | 0 companies |
| Phia Marie Bjuhr | Deputy Board Member | 0 companies |